Johns Hopkins University School of Medicine, Department of Psychiatry and Behavioral Sciences, Baltimore, Maryland.
Johns Hopkins University School of Medicine, Department of Neurology, Baltimore, Maryland.
J Clin Sleep Med. 2022 Feb 1;18(2):587-595. doi: 10.5664/jcsm.9676.
Individuals with opioid use disorder (OUD) may experience worsening sleep quality over time, and a subset of individuals may have sleep disturbances that precede opioid use and do not resolve following abstinence. The purpose of the present study was to (1) collect retrospective reports of sleep across the lifespan and (2) identify characteristics associated with persistent sleep disturbance and changes in sleep quality in persons with OUD.
Adults with OUD (n = 154) completed a cross-sectional study assessing current and past sleep disturbance, opioid use history, and chronic pain. Repeated-measures analysis of variance was used to examine changes in retrospectively reported sleep quality, and whether changes varied by screening positive for insomnia and/or chronic pain. Multivariate linear regression analyses were used to identify additional correlates of persistent sleep disturbance.
Participants reported that their sleep quality declined over their lifespan. Changes in reported sleep over time varied based on whether the individual screened positive for co-occurring insomnia and/or chronic pain. In regression analyses, female sex ( = 0.16, = .042), a greater number of treatment episodes ( = 0.20, = .024), and positive screens for chronic pain ( = 0.19, = .018) and insomnia (=0.22, = .013) were associated with self-reported persistent sleep disturbance. Only a portion of participants who screened positive for sleep disorders had received a formal diagnosis.
OUD treatment providers should routinely screen for co-occurring sleep disturbance and chronic pain. Interventions that treat co-occurring OUD, sleep disturbance, and chronic pain are needed.
Ellis JD, Mayo JL, Gamaldo CE, Finan PH, Huhn AS. Worsening sleep quality across the lifespan and persistent sleep disturbances in persons with opioid use disorder. . 2022;18(2):587-595.
阿片类药物使用障碍(OUD)患者的睡眠质量可能会随着时间的推移而恶化,且部分患者的睡眠障碍可能早于阿片类药物使用出现,且在戒断后无法得到解决。本研究的目的是:(1)收集终生的睡眠回顾报告;(2)确定与 OUD 患者持续性睡眠障碍和睡眠质量变化相关的特征。
154 名患有 OUD 的成年人完成了一项横断面研究,评估了当前和过去的睡眠障碍、阿片类药物使用史和慢性疼痛。使用重复测量方差分析来检查回顾性报告的睡眠质量变化,以及变化是否因失眠和/或慢性疼痛筛查阳性而有所不同。多变量线性回归分析用于确定持续性睡眠障碍的其他相关因素。
参与者报告称,他们的睡眠质量随着寿命的增长而下降。报告的睡眠时间随时间的变化取决于个体是否同时筛查出失眠和/或慢性疼痛。在回归分析中,女性( = 0.16, =.042)、更多的治疗次数( = 0.20, =.024)、慢性疼痛( = 0.19, =.018)和失眠( = 0.22, =.013)的阳性筛查结果与自我报告的持续性睡眠障碍相关。只有一部分筛查出睡眠障碍的参与者接受了正式诊断。
OUD 治疗提供者应常规筛查共病性睡眠障碍和慢性疼痛。需要干预来治疗共病的 OUD、睡眠障碍和慢性疼痛。
Ellis JD, Mayo JL, Gamaldo CE, Finan PH, Huhn AS. Worsening sleep quality across the lifespan and persistent sleep disturbances in persons with opioid use disorder.. 2022;18(2):587-595.